Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

Clinical trial NCT07162896 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07162896
Sponsor: Shalamar Institute of Health Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis Atopic Dermatitis (AD)

Start date: 2026-06-01
Primary completion: 2027-01-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.